| 期刊簡介 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Translational Lung Cancer Research LetPub Score 7.0
50 ratings
Rate
Reputation 8.2 Influence 6.0 Speed 7.0 | ||||||||||||||||
| 期刊簡稱 | TRANSL LUNG CANCER R | ||||||||||||||||
| ISSN | 2218-6751 | ||||||||||||||||
| h-index | N.A. | ||||||||||||||||
| CiteScore |
| ||||||||||||||||
| 自引率 (2023-2024) | 5.00%自引率趨勢 | ||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||
| 官方網站 | http://tlcr.amegroups.com/ | ||||||||||||||||
| 在線稿件提交 | http://tlcr.amegroups.com/login?source=%2Fauthor%2Fsubmit | ||||||||||||||||
| 開放訪問 | Yes | ||||||||||||||||
| 出版商 | Society for Translational Medicine (STM) | ||||||||||||||||
| 主題領域 | Medicine | ||||||||||||||||
| 出版國/地區 | Hong Kong | ||||||||||||||||
| 發行頻率 | 月刊 | ||||||||||||||||
| 創刊年 | 2012 | ||||||||||||||||
| 每年文章數 | 275每年文章數趨勢 | ||||||||||||||||
| 黃金OA百分比 | 100.00% | ||||||||||||||||
| Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2218-6751%5BISSN%5D | ||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: In-house review: 1-3 weeks External peer review: 1-3 months Publication Ahead of Print: within 1 month after being accepted | ||||||||||||||||
| 競爭力 * | 來自作者的數據: | ||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||
| *所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [Translational Lung Cancer Research] 的評論 | 撰寫評論 |
| 作者: Tdohappy 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-11-01 08:21:40 評論於 Submitted on August 25th, in the field of lung cancer pathology. Returned for revisions on October 23rd, minor revisions, only one concept explanation issue. Revised and resubmitted on October 30th, accepted on October 31st. The whole process was very smooth, and the editing efficiency was also very high. From the revision requirements, it is not apparent how many reviewers were invited. Only revision opinions were provided. Overall, the speed was quite good. |
| 作者: Tdohappy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-08-27 07:57:15 評論於 OP, how many steps are there in total? |
| 作者: jun 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-06-04 10:50:31 評論於 Do you want to ask if this journal accepts retrospective articles? |
| 作者: C219 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-03-05 12:15:39 評論於 Under Review (Step 2) Hello, may I ask what this status means? Has it already been sent for external review? |
| 作者: xxkk 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-09-19 15:20:58 評論於 Why is no one sharing their experience in this magazine? I submitted an article this year, let me tell you about it. It's a clinical article on thoracic surgery. It took 2 months for the initial review, then major revisions were needed. After resubmitting, it took another month for minor revisions and acceptance. It will be published in about a month, so the whole process took almost 4 to 5 months. The requirements are quite strict, and the reviewers are very thorough. Their feedback greatly improved the article, so there is a good opportunity for substantial revisions. |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us